<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/D6C3B4AF-36EC-4AFB-8274-A1A602646611"><gtr:id>D6C3B4AF-36EC-4AFB-8274-A1A602646611</gtr:id><gtr:name>King Edward VIII Hospital, Durban</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/6A8099D2-F2A3-449A-AE2A-09C16A65875D"><gtr:id>6A8099D2-F2A3-449A-AE2A-09C16A65875D</gtr:id><gtr:name>Harare Hospital</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/463E5F48-5015-4361-8608-FEBEF164E0A5"><gtr:id>463E5F48-5015-4361-8608-FEBEF164E0A5</gtr:id><gtr:name>Bangabandhu Sheikh Mujib Medical University (BSMMU)</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/6D374D20-24E8-459F-A9EA-C36A024454A2"><gtr:id>6D374D20-24E8-459F-A9EA-C36A024454A2</gtr:id><gtr:name>Komfo Anokye Teaching Hospital (KATH)</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/C653C512-1B63-43FB-889D-FFE39B880EA4"><gtr:id>C653C512-1B63-43FB-889D-FFE39B880EA4</gtr:id><gtr:name>University of Pretoria</gtr:name><gtr:address><gtr:line1>PO Box 667</gtr:line1><gtr:line4>Pretoria</gtr:line4><gtr:line5>0001</gtr:line5><gtr:region>Outside UK</gtr:region><gtr:country>South Africa</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/4A179E2C-FB5E-4836-AA80-6301F4DD5AB6"><gtr:id>4A179E2C-FB5E-4836-AA80-6301F4DD5AB6</gtr:id><gtr:name>University of Sydney</gtr:name><gtr:address><gtr:line1>University of Sydney</gtr:line1><gtr:region>Outside UK</gtr:region><gtr:country>Australia</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/28579FAD-F043-4636-8ED4-0BA89D52B359"><gtr:id>28579FAD-F043-4636-8ED4-0BA89D52B359</gtr:id><gtr:name>Fundacion Clinica Valle del Lili, Cali</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/C3FE1251-C9FE-4EDB-A824-082E34B3B503"><gtr:id>C3FE1251-C9FE-4EDB-A824-082E34B3B503</gtr:id><gtr:name>University Hospital of San Ignacio</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/9943714C-1C41-47FC-85BF-FFB8DF2BA118"><gtr:id>9943714C-1C41-47FC-85BF-FFB8DF2BA118</gtr:id><gtr:name>Christian Medical College Vellore</gtr:name><gtr:address><gtr:region>Outside UK</gtr:region></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/D1774113-D5D2-4B7C-A412-66A90FE4B96F"><gtr:id>D1774113-D5D2-4B7C-A412-66A90FE4B96F</gtr:id><gtr:name>University of Cambridge</gtr:name><gtr:address><gtr:line1>Lensfield Road</gtr:line1><gtr:line4>Cambridge</gtr:line4><gtr:postCode>CB2 1EW</gtr:postCode><gtr:region>East of England</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/7254835D-A811-460C-ACFC-C345775924B4"><gtr:id>7254835D-A811-460C-ACFC-C345775924B4</gtr:id><gtr:name>The Cochrane Collaboration</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/78308CAA-8483-45C0-A280-0AB4B6AD9D35"><gtr:id>78308CAA-8483-45C0-A280-0AB4B6AD9D35</gtr:id><gtr:name>Medical Research Council</gtr:name><gtr:address><gtr:line1>Polaris House</gtr:line1><gtr:line2>North Star Avenue</gtr:line2><gtr:postCode>SN2 1FL</gtr:postCode><gtr:region>South West</gtr:region></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/C85FEE8F-4918-4146-B2FF-E4A55389BF80"><gtr:id>C85FEE8F-4918-4146-B2FF-E4A55389BF80</gtr:id><gtr:name>Oregon Health and Science University</gtr:name><gtr:address><gtr:line1>Oregon Health and Science University</gtr:line1><gtr:line4>Portland</gtr:line4><gtr:line5>OR 97201-30</gtr:line5><gtr:region>Outside UK</gtr:region><gtr:country>United States</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/B2F6D466-223A-4449-9F3F-5C0EC198866F"><gtr:id>B2F6D466-223A-4449-9F3F-5C0EC198866F</gtr:id><gtr:name>KK Women and Childrens Hospital, Singapore</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/9B4CA5C7-E2C8-4736-BF8E-46D08D8D741E"><gtr:id>9B4CA5C7-E2C8-4736-BF8E-46D08D8D741E</gtr:id><gtr:name>Center for Perinatal Studies, Rosarino (CREP)</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/280687AA-D0A9-4C6B-B7F2-1445B439B8F0"><gtr:id>280687AA-D0A9-4C6B-B7F2-1445B439B8F0</gtr:id><gtr:name>Chris Hani Baragwanath Hospital</gtr:name><gtr:address><gtr:line1>PO Bertsham</gtr:line1><gtr:region>Unknown</gtr:region></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/9CCACE14-D408-441A-A72B-121091D042B7"><gtr:id>9CCACE14-D408-441A-A72B-121091D042B7</gtr:id><gtr:name>Jinnah Hospital</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/C412BAB0-990E-4CA0-972C-4C7847E386C8"><gtr:id>C412BAB0-990E-4CA0-972C-4C7847E386C8</gtr:id><gtr:name>Women's and Children's Hospital Foundation</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/DB5079E4-EF83-4AAE-B753-7E4C2283F0B0"><gtr:id>DB5079E4-EF83-4AAE-B753-7E4C2283F0B0</gtr:id><gtr:name>Royal Brisbane &amp; Women's Hospital</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/6C2807D9-715B-49E1-B034-92857163DDE6"><gtr:id>6C2807D9-715B-49E1-B034-92857163DDE6</gtr:id><gtr:name>Obstetrics and Gynaecology Princess Christian</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/D2A7E780-D923-4D61-B58E-3E467D303CA0"><gtr:id>D2A7E780-D923-4D61-B58E-3E467D303CA0</gtr:id><gtr:name>University of Adelaide</gtr:name><gtr:address><gtr:line1>Main Building</gtr:line1><gtr:line4>Adelaide</gtr:line4><gtr:line5>SA 5005</gtr:line5><gtr:region>Outside UK</gtr:region><gtr:country>Australia</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/947EE9D2-52BF-4766-9B0D-1C6523FD67CB"><gtr:id>947EE9D2-52BF-4766-9B0D-1C6523FD67CB</gtr:id><gtr:name>Assuit University Hospital, Egypt</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/BE957BA0-574E-450B-96C9-3F43EA952937"><gtr:id>BE957BA0-574E-450B-96C9-3F43EA952937</gtr:id><gtr:name>Hospital das Clinicas da UFPE</gtr:name></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9"><gtr:id>3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9</gtr:id><gtr:name>University of Oxford</gtr:name><gtr:department>RDM Clinical Laboratory Sciences</gtr:department><gtr:address><gtr:line1>University Chest</gtr:line1><gtr:line2>Wellington Square</gtr:line2><gtr:line4>Oxford</gtr:line4><gtr:postCode>OX1 2JD</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9"><gtr:id>3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9</gtr:id><gtr:name>University of Oxford</gtr:name><gtr:address><gtr:line1>University Chest</gtr:line1><gtr:line2>Wellington Square</gtr:line2><gtr:line4>Oxford</gtr:line4><gtr:postCode>OX1 2JD</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/D6C3B4AF-36EC-4AFB-8274-A1A602646611"><gtr:id>D6C3B4AF-36EC-4AFB-8274-A1A602646611</gtr:id><gtr:name>King Edward VIII Hospital, Durban</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/6A8099D2-F2A3-449A-AE2A-09C16A65875D"><gtr:id>6A8099D2-F2A3-449A-AE2A-09C16A65875D</gtr:id><gtr:name>Harare Hospital</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/463E5F48-5015-4361-8608-FEBEF164E0A5"><gtr:id>463E5F48-5015-4361-8608-FEBEF164E0A5</gtr:id><gtr:name>Bangabandhu Sheikh Mujib Medical University (BSMMU)</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/4A179E2C-FB5E-4836-AA80-6301F4DD5AB6"><gtr:id>4A179E2C-FB5E-4836-AA80-6301F4DD5AB6</gtr:id><gtr:name>University of Sydney</gtr:name><gtr:address><gtr:line1>University of Sydney</gtr:line1><gtr:region>Outside UK</gtr:region><gtr:country>Australia</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/28579FAD-F043-4636-8ED4-0BA89D52B359"><gtr:id>28579FAD-F043-4636-8ED4-0BA89D52B359</gtr:id><gtr:name>Fundacion Clinica Valle del Lili, Cali</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/9943714C-1C41-47FC-85BF-FFB8DF2BA118"><gtr:id>9943714C-1C41-47FC-85BF-FFB8DF2BA118</gtr:id><gtr:name>Christian Medical College Vellore</gtr:name><gtr:address><gtr:region>Outside UK</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/7254835D-A811-460C-ACFC-C345775924B4"><gtr:id>7254835D-A811-460C-ACFC-C345775924B4</gtr:id><gtr:name>The Cochrane Collaboration</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/C85FEE8F-4918-4146-B2FF-E4A55389BF80"><gtr:id>C85FEE8F-4918-4146-B2FF-E4A55389BF80</gtr:id><gtr:name>Oregon Health and Science University</gtr:name><gtr:address><gtr:line1>Oregon Health and Science University</gtr:line1><gtr:line4>Portland</gtr:line4><gtr:line5>OR 97201-30</gtr:line5><gtr:region>Outside UK</gtr:region><gtr:country>United States</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/B2F6D466-223A-4449-9F3F-5C0EC198866F"><gtr:id>B2F6D466-223A-4449-9F3F-5C0EC198866F</gtr:id><gtr:name>KK Women and Childrens Hospital, Singapore</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/280687AA-D0A9-4C6B-B7F2-1445B439B8F0"><gtr:id>280687AA-D0A9-4C6B-B7F2-1445B439B8F0</gtr:id><gtr:name>Chris Hani Baragwanath Hospital</gtr:name><gtr:address><gtr:line1>PO Bertsham</gtr:line1><gtr:region>Unknown</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/9CCACE14-D408-441A-A72B-121091D042B7"><gtr:id>9CCACE14-D408-441A-A72B-121091D042B7</gtr:id><gtr:name>Jinnah Hospital</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/C412BAB0-990E-4CA0-972C-4C7847E386C8"><gtr:id>C412BAB0-990E-4CA0-972C-4C7847E386C8</gtr:id><gtr:name>Women's and Children's Hospital Foundation</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/6C2807D9-715B-49E1-B034-92857163DDE6"><gtr:id>6C2807D9-715B-49E1-B034-92857163DDE6</gtr:id><gtr:name>Obstetrics and Gynaecology Princess Christian</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/947EE9D2-52BF-4766-9B0D-1C6523FD67CB"><gtr:id>947EE9D2-52BF-4766-9B0D-1C6523FD67CB</gtr:id><gtr:name>Assuit University Hospital, Egypt</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/6D374D20-24E8-459F-A9EA-C36A024454A2"><gtr:id>6D374D20-24E8-459F-A9EA-C36A024454A2</gtr:id><gtr:name>Komfo Anokye Teaching Hospital (KATH)</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/C653C512-1B63-43FB-889D-FFE39B880EA4"><gtr:id>C653C512-1B63-43FB-889D-FFE39B880EA4</gtr:id><gtr:name>University of Pretoria</gtr:name><gtr:address><gtr:line1>PO Box 667</gtr:line1><gtr:line4>Pretoria</gtr:line4><gtr:line5>0001</gtr:line5><gtr:region>Outside UK</gtr:region><gtr:country>South Africa</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/C3FE1251-C9FE-4EDB-A824-082E34B3B503"><gtr:id>C3FE1251-C9FE-4EDB-A824-082E34B3B503</gtr:id><gtr:name>University Hospital of San Ignacio</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/D1774113-D5D2-4B7C-A412-66A90FE4B96F"><gtr:id>D1774113-D5D2-4B7C-A412-66A90FE4B96F</gtr:id><gtr:name>University of Cambridge</gtr:name><gtr:address><gtr:line1>Lensfield Road</gtr:line1><gtr:line4>Cambridge</gtr:line4><gtr:postCode>CB2 1EW</gtr:postCode><gtr:region>East of England</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/78308CAA-8483-45C0-A280-0AB4B6AD9D35"><gtr:id>78308CAA-8483-45C0-A280-0AB4B6AD9D35</gtr:id><gtr:name>Medical Research Council</gtr:name><gtr:address><gtr:line1>Polaris House</gtr:line1><gtr:line2>North Star Avenue</gtr:line2><gtr:postCode>SN2 1FL</gtr:postCode><gtr:region>South West</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/9B4CA5C7-E2C8-4736-BF8E-46D08D8D741E"><gtr:id>9B4CA5C7-E2C8-4736-BF8E-46D08D8D741E</gtr:id><gtr:name>Center for Perinatal Studies, Rosarino (CREP)</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/DB5079E4-EF83-4AAE-B753-7E4C2283F0B0"><gtr:id>DB5079E4-EF83-4AAE-B753-7E4C2283F0B0</gtr:id><gtr:name>Royal Brisbane &amp; Women's Hospital</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/D2A7E780-D923-4D61-B58E-3E467D303CA0"><gtr:id>D2A7E780-D923-4D61-B58E-3E467D303CA0</gtr:id><gtr:name>University of Adelaide</gtr:name><gtr:address><gtr:line1>Main Building</gtr:line1><gtr:line4>Adelaide</gtr:line4><gtr:line5>SA 5005</gtr:line5><gtr:region>Outside UK</gtr:region><gtr:country>Australia</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/BE957BA0-574E-450B-96C9-3F43EA952937"><gtr:id>BE957BA0-574E-450B-96C9-3F43EA952937</gtr:id><gtr:name>Hospital das Clinicas da UFPE</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/936D002F-A8D1-4A93-AE5D-825ED0903D8D"><gtr:id>936D002F-A8D1-4A93-AE5D-825ED0903D8D</gtr:id><gtr:name>University of Nottingham</gtr:name><gtr:address><gtr:line1>University Park</gtr:line1><gtr:line4>Nottingham</gtr:line4><gtr:line5>Nottinghamshire</gtr:line5><gtr:postCode>NG7 2RD</gtr:postCode><gtr:region>East Midlands</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>FELLOW</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/58898F2F-6B78-4E08-BF9B-48CBBBE7C7FC"><gtr:id>58898F2F-6B78-4E08-BF9B-48CBBBE7C7FC</gtr:id><gtr:firstName>Lelia</gtr:firstName><gtr:surname>Duley</gtr:surname><gtr:roles><gtr:role><gtr:name>FELLOW</gtr:name></gtr:role><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=G116%2F98"><gtr:id>F3C839CB-107C-4489-BEF9-F4FDCA95E323</gtr:id><gtr:title>Improving outcome from hypertensive disorders of pregnancy: a programme of clinical trials and epidemiological studies</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Fellowship</gtr:grantCategory><gtr:grantReference>G116/98</gtr:grantReference><gtr:abstractText>Abstracts are not currently available in GtR for all funded research. This is normally because the abstract was not required at the time of proposal submission, but may be because it included sensitive information such as personal details.</gtr:abstractText><gtr:fund><gtr:end>2006-06-30</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>1999-07-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>769648</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>King Edward VIII Hospital, Durban</gtr:collaboratingOrganisation><gtr:country>South Africa, Republic of</gtr:country><gtr:description>Magpie Trial Follow up study Collaborative Group</gtr:description><gtr:id>D0D9E7F6-14DB-4FDD-AB7C-2E7FB21B4C50</gtr:id><gtr:impact>Support for magnesium sulphate as drug of choice for eclampsia and pre-eclampsia. Use of magneisum sulphate has now been implemented across the UK, and is incorporated into national and international guidelines - including the RCOG and WHO.</gtr:impact><gtr:outcomeId>DD45760A481-17</gtr:outcomeId><gtr:partnerContribution>Follow up of women and childrenCo-ordination of the follow up study in ArgentinaFollow up of women and childrenFollow up of women and childrenFollow up of women and childrenFollow up of women and childrenFollow up of women and childrenFollow up of women and childrenFollow up of women and childrenFollow up of women and childrenFollow up of women and childrenFollow up of women and childrenFollow up of women and childrenFollow up of women and childrenFollow up of women and childrenFollow up of women and childrenCo-ordination of follow up in South AfricaFollow up of women and childrenFollow up of women and children</gtr:partnerContribution><gtr:piContribution>Overall co-ordination, protocol development, trial materials, data management, analysis, writing up.</gtr:piContribution><gtr:sector>Hospitals</gtr:sector></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Assuit University Hospital, Egypt</gtr:collaboratingOrganisation><gtr:country>Egypt, Arab Republic of</gtr:country><gtr:department>Department of Obstetrics and Gynaecology</gtr:department><gtr:description>Magpie Trial Follow up study Collaborative Group</gtr:description><gtr:id>4C91A30B-56CC-4211-BC46-4459E4751071</gtr:id><gtr:impact>Support for magnesium sulphate as drug of choice for eclampsia and pre-eclampsia. Use of magneisum sulphate has now been implemented across the UK, and is incorporated into national and international guidelines - including the RCOG and WHO.</gtr:impact><gtr:outcomeId>DD45760A481-8</gtr:outcomeId><gtr:partnerContribution>Follow up of women and childrenCo-ordination of the follow up study in ArgentinaFollow up of women and childrenFollow up of women and childrenFollow up of women and childrenFollow up of women and childrenFollow up of women and childrenFollow up of women and childrenFollow up of women and childrenFollow up of women and childrenFollow up of women and childrenFollow up of women and childrenFollow up of women and childrenFollow up of women and childrenFollow up of women and childrenFollow up of women and childrenCo-ordination of follow up in South AfricaFollow up of women and childrenFollow up of women and children</gtr:partnerContribution><gtr:piContribution>Overall co-ordination, protocol development, trial materials, data management, analysis, writing up.</gtr:piContribution><gtr:sector>Hospitals</gtr:sector></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Royal Brisbane &amp; Women's Hospital</gtr:collaboratingOrganisation><gtr:country>Australia, Commonwealth of</gtr:country><gtr:department>Perinatal Research Centre Royal Brisbane</gtr:department><gtr:description>Magpie Trial Follow up study Collaborative Group</gtr:description><gtr:id>A0F7740C-1E88-49AC-92DF-06333E42B23C</gtr:id><gtr:impact>Support for magnesium sulphate as drug of choice for eclampsia and pre-eclampsia. Use of magneisum sulphate has now been implemented across the UK, and is incorporated into national and international guidelines - including the RCOG and WHO.</gtr:impact><gtr:outcomeId>DD45760A481-1</gtr:outcomeId><gtr:partnerContribution>Follow up of women and childrenCo-ordination of the follow up study in ArgentinaFollow up of women and childrenFollow up of women and childrenFollow up of women and childrenFollow up of women and childrenFollow up of women and childrenFollow up of women and childrenFollow up of women and childrenFollow up of women and childrenFollow up of women and childrenFollow up of women and childrenFollow up of women and childrenFollow up of women and childrenFollow up of women and childrenFollow up of women and childrenCo-ordination of follow up in South AfricaFollow up of women and childrenFollow up of women and children</gtr:partnerContribution><gtr:piContribution>Overall co-ordination, protocol development, trial materials, data management, analysis, writing up.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Jinnah Hospital</gtr:collaboratingOrganisation><gtr:country>Pakistan, Islamic Republic of</gtr:country><gtr:department>Jinnah Postgraduate Medical Centre (JPMC)</gtr:department><gtr:description>Magpie Trial Follow up study Collaborative Group</gtr:description><gtr:id>2D083E7D-3CAD-40E2-9823-2C7DEBCFC19B</gtr:id><gtr:impact>Support for magnesium sulphate as drug of choice for eclampsia and pre-eclampsia. Use of magneisum sulphate has now been implemented across the UK, and is incorporated into national and international guidelines - including the RCOG and WHO.</gtr:impact><gtr:outcomeId>DD45760A481-12</gtr:outcomeId><gtr:partnerContribution>Follow up of women and childrenCo-ordination of the follow up study in ArgentinaFollow up of women and childrenFollow up of women and childrenFollow up of women and childrenFollow up of women and childrenFollow up of women and childrenFollow up of women and childrenFollow up of women and childrenFollow up of women and childrenFollow up of women and childrenFollow up of women and childrenFollow up of women and childrenFollow up of women and childrenFollow up of women and childrenFollow up of women and childrenCo-ordination of follow up in South AfricaFollow up of women and childrenFollow up of women and children</gtr:partnerContribution><gtr:piContribution>Overall co-ordination, protocol development, trial materials, data management, analysis, writing up.</gtr:piContribution><gtr:sector>Hospitals</gtr:sector></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Medical Research Council (MRC)</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>MRC Clinical Trials Unit</gtr:department><gtr:description>PARIS collaborative group</gtr:description><gtr:id>28956C66-5092-4E46-B279-9C171E1AA6AE</gtr:id><gtr:impact>Lancet publication. Included in guidelines for prevention of pre-eclampsia, such as NICE</gtr:impact><gtr:outcomeId>0C26A48C901-3</gtr:outcomeId><gtr:partnerContribution>co-ordination and support for a systematic reivew and IPD meta analysistechincal support technical and software support</gtr:partnerContribution><gtr:piContribution>protocol development, project management, supervision</gtr:piContribution><gtr:sector>Public</gtr:sector></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Bangabandhu Sheikh Mujib Medical University (BSMMU)</gtr:collaboratingOrganisation><gtr:country>Bangladesh, People's Republic of</gtr:country><gtr:department>Obstetrics and Gynaecology</gtr:department><gtr:description>Magpie Trial Follow up study Collaborative Group</gtr:description><gtr:id>13136D6E-C676-47B4-BF35-1428093E0D7B</gtr:id><gtr:impact>Support for magnesium sulphate as drug of choice for eclampsia and pre-eclampsia. Use of magneisum sulphate has now been implemented across the UK, and is incorporated into national and international guidelines - including the RCOG and WHO.</gtr:impact><gtr:outcomeId>DD45760A481-4</gtr:outcomeId><gtr:partnerContribution>Follow up of women and childrenCo-ordination of the follow up study in ArgentinaFollow up of women and childrenFollow up of women and childrenFollow up of women and childrenFollow up of women and childrenFollow up of women and childrenFollow up of women and childrenFollow up of women and childrenFollow up of women and childrenFollow up of women and childrenFollow up of women and childrenFollow up of women and childrenFollow up of women and childrenFollow up of women and childrenFollow up of women and childrenCo-ordination of follow up in South AfricaFollow up of women and childrenFollow up of women and children</gtr:partnerContribution><gtr:piContribution>Overall co-ordination, protocol development, trial materials, data management, analysis, writing up.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Adelaide</gtr:collaboratingOrganisation><gtr:country>Australia, Commonwealth of</gtr:country><gtr:department>Discipline of Obstetrics and Gynaecology</gtr:department><gtr:description>AMICABLE</gtr:description><gtr:id>6A056EC6-76C8-4D41-8848-30E7D4BF3F06</gtr:id><gtr:impact>Collaborators meeting to agree protocol, protocol</gtr:impact><gtr:outcomeId>s2MMTJT5Nfz-1</gtr:outcomeId><gtr:partnerContribution>Co-ordination of individual patient data meta-analysis</gtr:partnerContribution><gtr:piContribution>Data for mothers and babies born before 32 weeks gestation</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2010-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Fundacion Clinica Valle del Lili, Cali</gtr:collaboratingOrganisation><gtr:country>Colombia, Republic of</gtr:country><gtr:department>Department of Obstetrics and Gynaecology</gtr:department><gtr:description>Magpie Trial Follow up study Collaborative Group</gtr:description><gtr:id>9F0189FE-BE0B-45AB-BBF6-AB6EA48065CE</gtr:id><gtr:impact>Support for magnesium sulphate as drug of choice for eclampsia and pre-eclampsia. Use of magneisum sulphate has now been implemented across the UK, and is incorporated into national and international guidelines - including the RCOG and WHO.</gtr:impact><gtr:outcomeId>DD45760A481-6</gtr:outcomeId><gtr:partnerContribution>Follow up of women and childrenCo-ordination of the follow up study in ArgentinaFollow up of women and childrenFollow up of women and childrenFollow up of women and childrenFollow up of women and childrenFollow up of women and childrenFollow up of women and childrenFollow up of women and childrenFollow up of women and childrenFollow up of women and childrenFollow up of women and childrenFollow up of women and childrenFollow up of women and childrenFollow up of women and childrenFollow up of women and childrenCo-ordination of follow up in South AfricaFollow up of women and childrenFollow up of women and children</gtr:partnerContribution><gtr:piContribution>Overall co-ordination, protocol development, trial materials, data management, analysis, writing up.</gtr:piContribution><gtr:sector>Hospitals</gtr:sector></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Women's and Children's Hospital Foundation</gtr:collaboratingOrganisation><gtr:country>Australia, Commonwealth of</gtr:country><gtr:description>Magpie Trial Follow up study Collaborative Group</gtr:description><gtr:id>368FF34E-0E79-4BBB-B560-C942375D8D35</gtr:id><gtr:impact>Support for magnesium sulphate as drug of choice for eclampsia and pre-eclampsia. Use of magneisum sulphate has now been implemented across the UK, and is incorporated into national and international guidelines - including the RCOG and WHO.</gtr:impact><gtr:outcomeId>DD45760A481-3</gtr:outcomeId><gtr:partnerContribution>Follow up of women and childrenCo-ordination of the follow up study in ArgentinaFollow up of women and childrenFollow up of women and childrenFollow up of women and childrenFollow up of women and childrenFollow up of women and childrenFollow up of women and childrenFollow up of women and childrenFollow up of women and childrenFollow up of women and childrenFollow up of women and childrenFollow up of women and childrenFollow up of women and childrenFollow up of women and childrenFollow up of women and childrenCo-ordination of follow up in South AfricaFollow up of women and childrenFollow up of women and children</gtr:partnerContribution><gtr:piContribution>Overall co-ordination, protocol development, trial materials, data management, analysis, writing up.</gtr:piContribution><gtr:sector>Charity/Non Profit</gtr:sector></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Hospital das Clinicas da UFPE</gtr:collaboratingOrganisation><gtr:country>Brazil, Federative Republic of</gtr:country><gtr:department>Department of Obstetrics and Gynaecology</gtr:department><gtr:description>Magpie Trial Follow up study Collaborative Group</gtr:description><gtr:id>305EDDCB-68B8-45D0-A162-F59D5E610BD9</gtr:id><gtr:impact>Support for magnesium sulphate as drug of choice for eclampsia and pre-eclampsia. Use of magneisum sulphate has now been implemented across the UK, and is incorporated into national and international guidelines - including the RCOG and WHO.</gtr:impact><gtr:outcomeId>DD45760A481-5</gtr:outcomeId><gtr:partnerContribution>Follow up of women and childrenCo-ordination of the follow up study in ArgentinaFollow up of women and childrenFollow up of women and childrenFollow up of women and childrenFollow up of women and childrenFollow up of women and childrenFollow up of women and childrenFollow up of women and childrenFollow up of women and childrenFollow up of women and childrenFollow up of women and childrenFollow up of women and childrenFollow up of women and childrenFollow up of women and childrenFollow up of women and childrenCo-ordination of follow up in South AfricaFollow up of women and childrenFollow up of women and children</gtr:partnerContribution><gtr:piContribution>Overall co-ordination, protocol development, trial materials, data management, analysis, writing up.</gtr:piContribution><gtr:sector>Hospitals</gtr:sector></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Harare Hospital</gtr:collaboratingOrganisation><gtr:country>Zimbabwe, Republic of</gtr:country><gtr:department>Obstetrics and Gynaecology Harare</gtr:department><gtr:description>Magpie Trial Follow up study Collaborative Group</gtr:description><gtr:id>F99A7A48-4C86-4BC7-B0A8-421D3E51ECFF</gtr:id><gtr:impact>Support for magnesium sulphate as drug of choice for eclampsia and pre-eclampsia. Use of magneisum sulphate has now been implemented across the UK, and is incorporated into national and international guidelines - including the RCOG and WHO.</gtr:impact><gtr:outcomeId>DD45760A481-19</gtr:outcomeId><gtr:partnerContribution>Follow up of women and childrenCo-ordination of the follow up study in ArgentinaFollow up of women and childrenFollow up of women and childrenFollow up of women and childrenFollow up of women and childrenFollow up of women and childrenFollow up of women and childrenFollow up of women and childrenFollow up of women and childrenFollow up of women and childrenFollow up of women and childrenFollow up of women and childrenFollow up of women and childrenFollow up of women and childrenFollow up of women and childrenCo-ordination of follow up in South AfricaFollow up of women and childrenFollow up of women and children</gtr:partnerContribution><gtr:piContribution>Overall co-ordination, protocol development, trial materials, data management, analysis, writing up.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University Hospital of San Ignacio</gtr:collaboratingOrganisation><gtr:country>Colombia, Republic of</gtr:country><gtr:department>Department of Obstetrics and Gynaecology</gtr:department><gtr:description>Magpie Trial Follow up study Collaborative Group</gtr:description><gtr:id>EF4347E8-0E1B-4FDC-999B-2DE4B0E99143</gtr:id><gtr:impact>Support for magnesium sulphate as drug of choice for eclampsia and pre-eclampsia. Use of magneisum sulphate has now been implemented across the UK, and is incorporated into national and international guidelines - including the RCOG and WHO.</gtr:impact><gtr:outcomeId>DD45760A481-7</gtr:outcomeId><gtr:partnerContribution>Follow up of women and childrenCo-ordination of the follow up study in ArgentinaFollow up of women and childrenFollow up of women and childrenFollow up of women and childrenFollow up of women and childrenFollow up of women and childrenFollow up of women and childrenFollow up of women and childrenFollow up of women and childrenFollow up of women and childrenFollow up of women and childrenFollow up of women and childrenFollow up of women and childrenFollow up of women and childrenFollow up of women and childrenCo-ordination of follow up in South AfricaFollow up of women and childrenFollow up of women and children</gtr:partnerContribution><gtr:piContribution>Overall co-ordination, protocol development, trial materials, data management, analysis, writing up.</gtr:piContribution><gtr:sector>Hospitals</gtr:sector></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Oregon Health and Science University</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:department>Department of Obstetrics and Gynaecology</gtr:department><gtr:description>Magpie Trial Follow up study Collaborative Group</gtr:description><gtr:id>7F199B53-54EC-427E-9012-5E33A60AD2DE</gtr:id><gtr:impact>Support for magnesium sulphate as drug of choice for eclampsia and pre-eclampsia. Use of magneisum sulphate has now been implemented across the UK, and is incorporated into national and international guidelines - including the RCOG and WHO.</gtr:impact><gtr:outcomeId>DD45760A481-18</gtr:outcomeId><gtr:partnerContribution>Follow up of women and childrenCo-ordination of the follow up study in ArgentinaFollow up of women and childrenFollow up of women and childrenFollow up of women and childrenFollow up of women and childrenFollow up of women and childrenFollow up of women and childrenFollow up of women and childrenFollow up of women and childrenFollow up of women and childrenFollow up of women and childrenFollow up of women and childrenFollow up of women and childrenFollow up of women and childrenFollow up of women and childrenCo-ordination of follow up in South AfricaFollow up of women and childrenFollow up of women and children</gtr:partnerContribution><gtr:piContribution>Overall co-ordination, protocol development, trial materials, data management, analysis, writing up.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Cambridge</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Department of Obstetrics &amp; Gynaecology</gtr:department><gtr:description>Magpie Trial Follow up study Collaborative Group</gtr:description><gtr:id>E40F7FE5-E562-4ECF-B29C-BDD1790F4B81</gtr:id><gtr:impact>Support for magnesium sulphate as drug of choice for eclampsia and pre-eclampsia. Use of magneisum sulphate has now been implemented across the UK, and is incorporated into national and international guidelines - including the RCOG and WHO.</gtr:impact><gtr:outcomeId>DD45760A481-11</gtr:outcomeId><gtr:partnerContribution>Follow up of women and childrenCo-ordination of the follow up study in ArgentinaFollow up of women and childrenFollow up of women and childrenFollow up of women and childrenFollow up of women and childrenFollow up of women and childrenFollow up of women and childrenFollow up of women and childrenFollow up of women and childrenFollow up of women and childrenFollow up of women and childrenFollow up of women and childrenFollow up of women and childrenFollow up of women and childrenFollow up of women and childrenCo-ordination of follow up in South AfricaFollow up of women and childrenFollow up of women and children</gtr:partnerContribution><gtr:piContribution>Overall co-ordination, protocol development, trial materials, data management, analysis, writing up.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Sydney</gtr:collaboratingOrganisation><gtr:country>Australia, Commonwealth of</gtr:country><gtr:department>NSW Centre for Perinatal Health Services Research</gtr:department><gtr:description>PARIS collaborative group</gtr:description><gtr:id>0E52C677-DC48-4491-A588-3A898702971B</gtr:id><gtr:impact>Lancet publication. Included in guidelines for prevention of pre-eclampsia, such as NICE</gtr:impact><gtr:outcomeId>0C26A48C901-1</gtr:outcomeId><gtr:partnerContribution>co-ordination and support for a systematic reivew and IPD meta analysistechincal support technical and software support</gtr:partnerContribution><gtr:piContribution>protocol development, project management, supervision</gtr:piContribution><gtr:sector>Academic/University</gtr:sector></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>KK Women and Childrens Hospital, Singapore</gtr:collaboratingOrganisation><gtr:country>Singapore, Republic of</gtr:country><gtr:department>Obstetrics and Gynaecology KK Women and Childrens</gtr:department><gtr:description>Magpie Trial Follow up study Collaborative Group</gtr:description><gtr:id>A86C2C26-2DA2-41FB-BD4B-FD531A346B51</gtr:id><gtr:impact>Support for magnesium sulphate as drug of choice for eclampsia and pre-eclampsia. Use of magneisum sulphate has now been implemented across the UK, and is incorporated into national and international guidelines - including the RCOG and WHO.</gtr:impact><gtr:outcomeId>DD45760A481-14</gtr:outcomeId><gtr:partnerContribution>Follow up of women and childrenCo-ordination of the follow up study in ArgentinaFollow up of women and childrenFollow up of women and childrenFollow up of women and childrenFollow up of women and childrenFollow up of women and childrenFollow up of women and childrenFollow up of women and childrenFollow up of women and childrenFollow up of women and childrenFollow up of women and childrenFollow up of women and childrenFollow up of women and childrenFollow up of women and childrenFollow up of women and childrenCo-ordination of follow up in South AfricaFollow up of women and childrenFollow up of women and children</gtr:partnerContribution><gtr:piContribution>Overall co-ordination, protocol development, trial materials, data management, analysis, writing up.</gtr:piContribution><gtr:sector>Hospitals</gtr:sector></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Christian Medical College, Vellore</gtr:collaboratingOrganisation><gtr:country>India, Republic of</gtr:country><gtr:department>Obstetrics and Gynaecology Christian Medical College</gtr:department><gtr:description>Magpie Trial Follow up study Collaborative Group</gtr:description><gtr:id>71DF0380-24D2-414A-BB4A-CBEE1E8F398F</gtr:id><gtr:impact>Support for magnesium sulphate as drug of choice for eclampsia and pre-eclampsia. Use of magneisum sulphate has now been implemented across the UK, and is incorporated into national and international guidelines - including the RCOG and WHO.</gtr:impact><gtr:outcomeId>DD45760A481-10</gtr:outcomeId><gtr:partnerContribution>Follow up of women and childrenCo-ordination of the follow up study in ArgentinaFollow up of women and childrenFollow up of women and childrenFollow up of women and childrenFollow up of women and childrenFollow up of women and childrenFollow up of women and childrenFollow up of women and childrenFollow up of women and childrenFollow up of women and childrenFollow up of women and childrenFollow up of women and childrenFollow up of women and childrenFollow up of women and childrenFollow up of women and childrenCo-ordination of follow up in South AfricaFollow up of women and childrenFollow up of women and children</gtr:partnerContribution><gtr:piContribution>Overall co-ordination, protocol development, trial materials, data management, analysis, writing up.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Komfo Anokye Teaching Hospital (KATH)</gtr:collaboratingOrganisation><gtr:country>Ghana, Republic of</gtr:country><gtr:department>Obstetrics and Gynaecology Directorate KATH</gtr:department><gtr:description>Magpie Trial Follow up study Collaborative Group</gtr:description><gtr:id>5EA5B382-478E-49B3-9AFB-34A3AF5795D8</gtr:id><gtr:impact>Support for magnesium sulphate as drug of choice for eclampsia and pre-eclampsia. Use of magneisum sulphate has now been implemented across the UK, and is incorporated into national and international guidelines - including the RCOG and WHO.</gtr:impact><gtr:outcomeId>DD45760A481-9</gtr:outcomeId><gtr:partnerContribution>Follow up of women and childrenCo-ordination of the follow up study in ArgentinaFollow up of women and childrenFollow up of women and childrenFollow up of women and childrenFollow up of women and childrenFollow up of women and childrenFollow up of women and childrenFollow up of women and childrenFollow up of women and childrenFollow up of women and childrenFollow up of women and childrenFollow up of women and childrenFollow up of women and childrenFollow up of women and childrenFollow up of women and childrenCo-ordination of follow up in South AfricaFollow up of women and childrenFollow up of women and children</gtr:partnerContribution><gtr:piContribution>Overall co-ordination, protocol development, trial materials, data management, analysis, writing up.</gtr:piContribution><gtr:sector>Hospitals</gtr:sector></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Obstetrics and Gynaecology Princess Christian</gtr:collaboratingOrganisation><gtr:country>Sierra Leone, Republic of</gtr:country><gtr:description>Magpie Trial Follow up study Collaborative Group</gtr:description><gtr:id>8BD259F9-B858-4BCB-BE04-809F227AA0B1</gtr:id><gtr:impact>Support for magnesium sulphate as drug of choice for eclampsia and pre-eclampsia. Use of magneisum sulphate has now been implemented across the UK, and is incorporated into national and international guidelines - including the RCOG and WHO.</gtr:impact><gtr:outcomeId>DD45760A481-13</gtr:outcomeId><gtr:partnerContribution>Follow up of women and childrenCo-ordination of the follow up study in ArgentinaFollow up of women and childrenFollow up of women and childrenFollow up of women and childrenFollow up of women and childrenFollow up of women and childrenFollow up of women and childrenFollow up of women and childrenFollow up of women and childrenFollow up of women and childrenFollow up of women and childrenFollow up of women and childrenFollow up of women and childrenFollow up of women and childrenFollow up of women and childrenCo-ordination of follow up in South AfricaFollow up of women and childrenFollow up of women and children</gtr:partnerContribution><gtr:piContribution>Overall co-ordination, protocol development, trial materials, data management, analysis, writing up.</gtr:piContribution><gtr:sector>Hospitals</gtr:sector></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Chris Hani Baragwanath Hospital</gtr:collaboratingOrganisation><gtr:country>South Africa, Republic of</gtr:country><gtr:department>Obstetrics and Gynaecology Baragwanath</gtr:department><gtr:description>Magpie Trial Follow up study Collaborative Group</gtr:description><gtr:id>3F49BECA-1B66-4CD0-BE07-413C74DFAD20</gtr:id><gtr:impact>Support for magnesium sulphate as drug of choice for eclampsia and pre-eclampsia. Use of magneisum sulphate has now been implemented across the UK, and is incorporated into national and international guidelines - including the RCOG and WHO.</gtr:impact><gtr:outcomeId>DD45760A481-15</gtr:outcomeId><gtr:partnerContribution>Follow up of women and childrenCo-ordination of the follow up study in ArgentinaFollow up of women and childrenFollow up of women and childrenFollow up of women and childrenFollow up of women and childrenFollow up of women and childrenFollow up of women and childrenFollow up of women and childrenFollow up of women and childrenFollow up of women and childrenFollow up of women and childrenFollow up of women and childrenFollow up of women and childrenFollow up of women and childrenFollow up of women and childrenCo-ordination of follow up in South AfricaFollow up of women and childrenFollow up of women and children</gtr:partnerContribution><gtr:piContribution>Overall co-ordination, protocol development, trial materials, data management, analysis, writing up.</gtr:piContribution><gtr:sector>Hospitals</gtr:sector></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Center for Perinatal Studies, Rosarino (CREP)</gtr:collaboratingOrganisation><gtr:country>Argentina, Argentine Republic</gtr:country><gtr:description>Magpie Trial Follow up study Collaborative Group</gtr:description><gtr:id>12BCE779-8B3F-4FAF-B54E-22E3D281031F</gtr:id><gtr:impact>Support for magnesium sulphate as drug of choice for eclampsia and pre-eclampsia. Use of magneisum sulphate has now been implemented across the UK, and is incorporated into national and international guidelines - including the RCOG and WHO.</gtr:impact><gtr:outcomeId>DD45760A481-2</gtr:outcomeId><gtr:partnerContribution>Follow up of women and childrenCo-ordination of the follow up study in ArgentinaFollow up of women and childrenFollow up of women and childrenFollow up of women and childrenFollow up of women and childrenFollow up of women and childrenFollow up of women and childrenFollow up of women and childrenFollow up of women and childrenFollow up of women and childrenFollow up of women and childrenFollow up of women and childrenFollow up of women and childrenFollow up of women and childrenFollow up of women and childrenCo-ordination of follow up in South AfricaFollow up of women and childrenFollow up of women and children</gtr:partnerContribution><gtr:piContribution>Overall co-ordination, protocol development, trial materials, data management, analysis, writing up.</gtr:piContribution><gtr:sector>Charity/Non Profit</gtr:sector></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Pretoria</gtr:collaboratingOrganisation><gtr:country>South Africa, Republic of</gtr:country><gtr:department>Obstetrics and Gynaecology Pretoria</gtr:department><gtr:description>Magpie Trial Follow up study Collaborative Group</gtr:description><gtr:id>F9833C2B-8359-4FF7-9380-1BD0D7ECA5D1</gtr:id><gtr:impact>Support for magnesium sulphate as drug of choice for eclampsia and pre-eclampsia. Use of magneisum sulphate has now been implemented across the UK, and is incorporated into national and international guidelines - including the RCOG and WHO.</gtr:impact><gtr:outcomeId>DD45760A481-16</gtr:outcomeId><gtr:partnerContribution>Follow up of women and childrenCo-ordination of the follow up study in ArgentinaFollow up of women and childrenFollow up of women and childrenFollow up of women and childrenFollow up of women and childrenFollow up of women and childrenFollow up of women and childrenFollow up of women and childrenFollow up of women and childrenFollow up of women and childrenFollow up of women and childrenFollow up of women and childrenFollow up of women and childrenFollow up of women and childrenFollow up of women and childrenCo-ordination of follow up in South AfricaFollow up of women and childrenFollow up of women and children</gtr:partnerContribution><gtr:piContribution>Overall co-ordination, protocol development, trial materials, data management, analysis, writing up.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>The Cochrane Collaboration</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>UK Cochrane Centre</gtr:department><gtr:description>PARIS collaborative group</gtr:description><gtr:id>5E0A952A-7C0A-463D-8BB1-59404492E152</gtr:id><gtr:impact>Lancet publication. Included in guidelines for prevention of pre-eclampsia, such as NICE</gtr:impact><gtr:outcomeId>0C26A48C901-2</gtr:outcomeId><gtr:partnerContribution>co-ordination and support for a systematic reivew and IPD meta analysistechincal support technical and software support</gtr:partnerContribution><gtr:piContribution>protocol development, project management, supervision</gtr:piContribution><gtr:sector>Charity/Non Profit</gtr:sector></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>postal newsletter - results for participants</gtr:description><gtr:form>A magazine, newsletter or online publication</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>DEE57C8A-9367-4947-AC74-6C891C1C4D38</gtr:id><gtr:impact>Results of research sent to participants in Magpie Trial

Previous expereince is that women value this feedback</gtr:impact><gtr:outcomeId>8A7BBE41BB4</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Participants in your research and patient groups</gtr:primaryAudience><gtr:year>2006</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>300000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>MRC Methodology</gtr:description><gtr:end>2012-09-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:id>C4315CAC-0721-4B26-AE89-050BE0283137</gtr:id><gtr:outcomeId>651E9B4DEF00</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2009-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>153852</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>MRC Global Health Joint call</gtr:description><gtr:end>2016-12-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:fundingRef>MR/M017397/1</gtr:fundingRef><gtr:id>78360AE8-E57A-4722-857C-4EDE1EB621D5</gtr:id><gtr:outcomeId>apP2YShkgj4</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2014-11-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>1821977</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Improving quality of care and outcome at very preterm birth</gtr:description><gtr:end>2016-02-02</gtr:end><gtr:fundingOrg>National Institute for Health Research</gtr:fundingOrg><gtr:id>F2106673-12FC-4ECF-BEA5-A228B215A9E8</gtr:id><gtr:outcomeId>DRNhiFVWoLc0</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2011-03-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Cochrane review</gtr:description><gtr:geographicReach>Multiple continents/international</gtr:geographicReach><gtr:id>D346CEEC-9813-4EB2-8A53-2D1BE9CA56D2</gtr:id><gtr:impact>Supports use of magnesium sulphate for pre-eclampsi and eclampsia</gtr:impact><gtr:outcomeId>386A9448F20</gtr:outcomeId><gtr:type>Citation in systematic reviews</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Citation in Cochrane review</gtr:description><gtr:geographicReach>Multiple continents/international</gtr:geographicReach><gtr:guidelineTitle>Hypertension in pregnancy</gtr:guidelineTitle><gtr:id>F1287276-BB48-4825-87E0-3EA050525AF6</gtr:id><gtr:impact>Change in policy and practice for women with pre-eclampsia</gtr:impact><gtr:outcomeId>rwjvp6vFK1Z</gtr:outcomeId><gtr:type>Citation in clinical guidelines</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>citation to trial report, citation in Cochrane review</gtr:description><gtr:geographicReach>Multiple continents/international</gtr:geographicReach><gtr:guidelineTitle>RCOG greentop guideline, treatment for women with pre-eclampsia</gtr:guidelineTitle><gtr:id>E71CBD4F-C774-4267-ADBE-A5EA8C87D7B5</gtr:id><gtr:impact>Contributing to reduction in maternal mortality and morbidity</gtr:impact><gtr:outcomeId>ACHTk6WHcFB</gtr:outcomeId><gtr:type>Citation in clinical guidelines</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>NICE</gtr:description><gtr:geographicReach>Multiple continents/international</gtr:geographicReach><gtr:guidelineTitle>NICE Hypertension in Pregnancy</gtr:guidelineTitle><gtr:id>1950DE01-036A-4CE4-AD81-4998C15846C5</gtr:id><gtr:impact>Reduction in eclampsia</gtr:impact><gtr:outcomeId>F69E2A826B0</gtr:outcomeId><gtr:type>Citation in clinical guidelines</gtr:type><gtr:url>http://www.nice.org.uk/CG107</gtr:url></gtr:policyInfluenceOutput></gtr:policyInfluenceOutputs><gtr:productOutputs><gtr:productOutput><gtr:clinicalTrial>true</gtr:clinicalTrial><gtr:description>magnesium sulphate for prevention of eclampsia</gtr:description><gtr:id>6021D901-93BB-4803-9B6D-BD90C82CC309</gtr:id><gtr:impact>Changed practice in the UK - now standard care. Also wide impact internationallly</gtr:impact><gtr:outcomeId>NE4k2j9Z7rC</gtr:outcomeId><gtr:stage>Late clinical evaluation</gtr:stage><gtr:status>Closed</gtr:status><gtr:title>Magpie Trial - magnesium sulphate</gtr:title><gtr:type>Therapeutic Intervention - Drug</gtr:type></gtr:productOutput></gtr:productOutputs><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs><gtr:researchMaterialOutput><gtr:description>Shortened version of the Ages and Stages Questionnaire</gtr:description><gtr:id>531ACEB8-7838-42D2-8B9D-161BBE513446</gtr:id><gtr:impact>Publication of our experience with the short ASQ.</gtr:impact><gtr:outcomeId>BAADEAA3E2A</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>Short ASQ</gtr:title><gtr:type>Physiological assessment or outcome measure</gtr:type><gtr:yearFirstProvided>2006</gtr:yearFirstProvided></gtr:researchMaterialOutput></gtr:researchMaterialOutputs><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>C27CC8D6-65C6-4DBC-BF6B-F1DD651DC6B0</gtr:id><gtr:title>Nitric oxide for preventing pre-eclampsia and its complications.</gtr:title><gtr:parentPublicationTitle>The Cochrane database of systematic reviews</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ddd7f361ee04efc2d603dd0d819b5059"><gtr:id>ddd7f361ee04efc2d603dd0d819b5059</gtr:id><gtr:otherNames>Meher S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>1361-6137</gtr:issn><gtr:outcomeId>8646D0D78FD</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F9040E27-B907-44C3-9457-119DAB27E2B0</gtr:id><gtr:title>Marine oil, and other prostaglandin precursor, supplementation for pregnancy uncomplicated by pre-eclampsia or intrauterine growth restriction.</gtr:title><gtr:parentPublicationTitle>The Cochrane database of systematic reviews</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1f1ff90d36a62309b2ec9f12be273a8c"><gtr:id>1f1ff90d36a62309b2ec9f12be273a8c</gtr:id><gtr:otherNames>Makrides M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>1361-6137</gtr:issn><gtr:outcomeId>2FE4D903BC4</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8CE07A3C-A4FE-48BC-93E0-ACA49F708346</gtr:id><gtr:title>Magpie Trial in the UK: methods and additional data for women and children at 2 years following pregnancy complicated by pre-eclampsia.</gtr:title><gtr:parentPublicationTitle>BMC pregnancy and childbirth</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6bd7807b7e314ccca158a271ae22f156"><gtr:id>6bd7807b7e314ccca158a271ae22f156</gtr:id><gtr:otherNames>Smyth RM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1471-2393</gtr:issn><gtr:outcomeId>2CA5AD4D949</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>EBF8E3CC-F29A-49A0-BC70-93A83B324B46</gtr:id><gtr:title>Women's experiences of participating in the Magpie Trial: a postal survey in the United Kingdom.</gtr:title><gtr:parentPublicationTitle>Birth (Berkeley, Calif.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6bd7807b7e314ccca158a271ae22f156"><gtr:id>6bd7807b7e314ccca158a271ae22f156</gtr:id><gtr:otherNames>Smyth RM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0730-7659</gtr:issn><gtr:outcomeId>5613762874F</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F78E07AD-DC83-4BF9-9140-B8599BDC52C4</gtr:id><gtr:title>Drugs for treatment of very high blood pressure during pregnancy.</gtr:title><gtr:parentPublicationTitle>The Cochrane database of systematic reviews</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/eb3d1e6636ccda1a8d492848b642a285"><gtr:id>eb3d1e6636ccda1a8d492848b642a285</gtr:id><gtr:otherNames>Duley L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>1361-6137</gtr:issn><gtr:outcomeId>0E02EED4A4C</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1898FEEB-886E-4002-83D9-B57D90C64643</gtr:id><gtr:title>Magnesium sulphate versus phenytoin for eclampsia.</gtr:title><gtr:parentPublicationTitle>The Cochrane database of systematic reviews</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/eb3d1e6636ccda1a8d492848b642a285"><gtr:id>eb3d1e6636ccda1a8d492848b642a285</gtr:id><gtr:otherNames>Duley L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1361-6137</gtr:issn><gtr:outcomeId>J6wNUP3aBFa</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B8C5588C-15F5-4153-BC06-1DB6B3017D1D</gtr:id><gtr:title>The Magpie Trial: a randomised trial comparing magnesium sulphate with placebo for pre-eclampsia. Outcome for women at 2 years.</gtr:title><gtr:parentPublicationTitle>BJOG : an international journal of obstetrics and gynaecology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/33b4507f110ca33235519d72d3213df1"><gtr:id>33b4507f110ca33235519d72d3213df1</gtr:id><gtr:otherNames>Magpie Trial Follow-Up Study Collaborative Group</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>1470-0328</gtr:issn><gtr:outcomeId>90DFBCD9F70</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>60D2210F-F1FD-43AE-9D3F-464130BA4D1A</gtr:id><gtr:title>A systematic review of maternal and infant outcomes following magnesium sulfate for pre-eclampsia/eclampsia in real-world use.</gtr:title><gtr:parentPublicationTitle>International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0599af2ca345645716b33e76caa230fb"><gtr:id>0599af2ca345645716b33e76caa230fb</gtr:id><gtr:otherNames>McDonald SD</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0020-7292</gtr:issn><gtr:outcomeId>pm_16467_27_22703834</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>981D2AB2-8BD1-4374-A4C4-48C99B280A62</gtr:id><gtr:title>Interventionist versus expectant care for severe pre-eclampsia between 24 and 34 weeks' gestation.</gtr:title><gtr:parentPublicationTitle>The Cochrane database of systematic reviews</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/82f013a0987af324b617005307846005"><gtr:id>82f013a0987af324b617005307846005</gtr:id><gtr:otherNames>Churchill D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1361-6137</gtr:issn><gtr:outcomeId>pm_16467_27_23888485</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>876A87FB-2F0A-4A96-8C8E-8DCD8B5EDE27</gtr:id><gtr:title>Drugs for treatment of very high blood pressure during pregnancy.</gtr:title><gtr:parentPublicationTitle>The Cochrane database of systematic reviews</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/eb3d1e6636ccda1a8d492848b642a285"><gtr:id>eb3d1e6636ccda1a8d492848b642a285</gtr:id><gtr:otherNames>Duley L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1361-6137</gtr:issn><gtr:outcomeId>pm_16467_27_23900968</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A02FAFD6-424A-4E2F-8B3C-646E838B2FE5</gtr:id><gtr:title>Antioxidants for preventing pre-eclampsia.</gtr:title><gtr:parentPublicationTitle>The Cochrane database of systematic reviews</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c7e98d42d7c44200866765b3f6c623ac"><gtr:id>c7e98d42d7c44200866765b3f6c623ac</gtr:id><gtr:otherNames>Rumbold A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>1361-6137</gtr:issn><gtr:outcomeId>E0D838C677D</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>30368DF1-3EFA-4ABB-97E2-2605CED38B26</gtr:id><gtr:title>Antiplatelet agents for prevention of pre-eclampsia: a meta-analysis of individual patient data.</gtr:title><gtr:parentPublicationTitle>Lancet (London, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/51745a911dc9ecd1f48fca348ed3b6f7"><gtr:id>51745a911dc9ecd1f48fca348ed3b6f7</gtr:id><gtr:otherNames>Askie LM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0140-6736</gtr:issn><gtr:outcomeId>A4DD5047A3A</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>959E53E8-B3E9-425A-B97C-6AC6F61C3C66</gtr:id><gtr:title>Magnesium sulphate versus diazepam for eclampsia.</gtr:title><gtr:parentPublicationTitle>The Cochrane database of systematic reviews</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/eb3d1e6636ccda1a8d492848b642a285"><gtr:id>eb3d1e6636ccda1a8d492848b642a285</gtr:id><gtr:otherNames>Duley L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1361-6137</gtr:issn><gtr:outcomeId>dYJbNvphB5G</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>50F31056-BA44-4EF8-B1C2-2BB44E281135</gtr:id><gtr:title>Clinical pharmacokinetic properties of magnesium sulphate in women with pre-eclampsia and eclampsia.</gtr:title><gtr:parentPublicationTitle>BJOG : an international journal of obstetrics and gynaecology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3cccbdbe9c4c0bf0ca6f0c376cb3bda0"><gtr:id>3cccbdbe9c4c0bf0ca6f0c376cb3bda0</gtr:id><gtr:otherNames>Okusanya BO</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1470-0328</gtr:issn><gtr:outcomeId>58c6a562e05406.67462983</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>293A3CD2-40F2-4EAD-9F65-1543B7DFD6D8</gtr:id><gtr:title>Doing the undoable: Magpie Trial long-term follow-up.</gtr:title><gtr:parentPublicationTitle>Lancet (London, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/81d44c9aab100b0f04ed98d8c976f979"><gtr:id>81d44c9aab100b0f04ed98d8c976f979</gtr:id><gtr:otherNames>Farrell B</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0140-6736</gtr:issn><gtr:outcomeId>7FF78A7DCD3</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>FD82CD57-D735-4687-90F6-0285CADAE0FB</gtr:id><gtr:title>Methods of prediction and prevention of pre-eclampsia: systematic reviews of accuracy and effectiveness literature with economic modelling.</gtr:title><gtr:parentPublicationTitle>Health technology assessment (Winchester, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/deab99b75faf26771cc0008d8700ee52"><gtr:id>deab99b75faf26771cc0008d8700ee52</gtr:id><gtr:otherNames>Meads CA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>1366-5278</gtr:issn><gtr:outcomeId>F7E509E8DC0</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>631506E2-5C08-431D-9516-D08D23912730</gtr:id><gtr:title>Assessing the neuroprotective benefits for babies of antenatal magnesium sulphate: An individual participant data meta-analysis.</gtr:title><gtr:parentPublicationTitle>PLoS medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b07ea4f8cabb61f3c0af162e55761416"><gtr:id>b07ea4f8cabb61f3c0af162e55761416</gtr:id><gtr:otherNames>Crowther CA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1549-1277</gtr:issn><gtr:outcomeId>5a7073a3c4b3a7.55361679</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>70BCE302-6C53-415F-998F-408AEFE09C2D</gtr:id><gtr:title>Magnesium sulphate and other anticonvulsants for women with pre-eclampsia.</gtr:title><gtr:parentPublicationTitle>The Cochrane database of systematic reviews</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/eb3d1e6636ccda1a8d492848b642a285"><gtr:id>eb3d1e6636ccda1a8d492848b642a285</gtr:id><gtr:otherNames>Duley L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1361-6137</gtr:issn><gtr:outcomeId>ghWmy92X4yX</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8E351448-8227-485E-9803-BFF333C12C4B</gtr:id><gtr:title>Randomised trials relevant to mental health conducted in low and middle-income countries: a survey.</gtr:title><gtr:parentPublicationTitle>BMC psychiatry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/57a3eb1036607a6c2374c8507f1fb85d"><gtr:id>57a3eb1036607a6c2374c8507f1fb85d</gtr:id><gtr:otherNames>Sheriff RJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>1471-244X</gtr:issn><gtr:outcomeId>D9487616FC3</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>52B79258-F2B2-4132-8740-17CDD200F36C</gtr:id><gtr:title>Evaluation of the Ages and Stages Questionnaires in identifying children with neurosensory disability in the Magpie Trial follow-up study.</gtr:title><gtr:parentPublicationTitle>Acta paediatrica (Oslo, Norway : 1992)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0205c2ac34e9cd16ccca71f123e81580"><gtr:id>0205c2ac34e9cd16ccca71f123e81580</gtr:id><gtr:otherNames>Yu LM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0803-5253</gtr:issn><gtr:outcomeId>6200F0C74B0</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A0C00727-7A40-4E64-A83C-AAA7D9FFC69B</gtr:id><gtr:title>The Magpie Trial: a randomised trial comparing magnesium sulphate with placebo for pre-eclampsia. Outcome for children at 18 months.</gtr:title><gtr:parentPublicationTitle>BJOG : an international journal of obstetrics and gynaecology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/33b4507f110ca33235519d72d3213df1"><gtr:id>33b4507f110ca33235519d72d3213df1</gtr:id><gtr:otherNames>Magpie Trial Follow-Up Study Collaborative Group</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>1470-0328</gtr:issn><gtr:outcomeId>4AC3CE19AB4</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>27D5017F-4B22-4D81-ABBF-A0F55EA29823</gtr:id><gtr:title>Antiplatelet agents for preventing pre-eclampsia and its complications.</gtr:title><gtr:parentPublicationTitle>The Cochrane database of systematic reviews</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/eb3d1e6636ccda1a8d492848b642a285"><gtr:id>eb3d1e6636ccda1a8d492848b642a285</gtr:id><gtr:otherNames>Duley L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>1361-6137</gtr:issn><gtr:outcomeId>BE8D366E237</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3D6D2553-03DA-4BB6-8E99-5D1503657958</gtr:id><gtr:title>Rest during pregnancy for preventing pre-eclampsia and its complications in women with normal blood pressure.</gtr:title><gtr:parentPublicationTitle>The Cochrane database of systematic reviews</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ddd7f361ee04efc2d603dd0d819b5059"><gtr:id>ddd7f361ee04efc2d603dd0d819b5059</gtr:id><gtr:otherNames>Meher S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>1361-6137</gtr:issn><gtr:outcomeId>98B363FC11E</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0B27929F-B64E-4450-9964-5093649AED6F</gtr:id><gtr:title>Cost-effectiveness of prophylactic magnesium sulphate for 9996 women with pre-eclampsia from 33 countries: economic evaluation of the Magpie Trial.</gtr:title><gtr:parentPublicationTitle>BJOG : an international journal of obstetrics and gynaecology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5abe14897f7cb07755c12d1198c633db"><gtr:id>5abe14897f7cb07755c12d1198c633db</gtr:id><gtr:otherNames>Simon J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>1470-0328</gtr:issn><gtr:outcomeId>5EC4C32009B</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>88E6AAC4-39ED-49BD-A6CF-356F028706CC</gtr:id><gtr:title>What are the main inefficiencies in trial conduct: a survey of UKCRC registered clinical trials units in the UK.</gtr:title><gtr:parentPublicationTitle>Trials</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/eb3d1e6636ccda1a8d492848b642a285"><gtr:id>eb3d1e6636ccda1a8d492848b642a285</gtr:id><gtr:otherNames>Duley L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2018-01-01</gtr:date><gtr:issn>1745-6215</gtr:issn><gtr:outcomeId>5a7071eb76c9d4.36553730</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6A44969C-1363-4D0D-813A-A868A18A236E</gtr:id><gtr:title>Progesterone for preventing pre-eclampsia and its complications.</gtr:title><gtr:parentPublicationTitle>The Cochrane database of systematic reviews</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ddd7f361ee04efc2d603dd0d819b5059"><gtr:id>ddd7f361ee04efc2d603dd0d819b5059</gtr:id><gtr:otherNames>Meher S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>1361-6137</gtr:issn><gtr:outcomeId>07915B44A6C</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>60EFB012-3A60-4B7B-B648-1D5453484237</gtr:id><gtr:title>Alternative magnesium sulphate regimens for women with pre-eclampsia and eclampsia.</gtr:title><gtr:parentPublicationTitle>The Cochrane database of systematic reviews</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/eb3d1e6636ccda1a8d492848b642a285"><gtr:id>eb3d1e6636ccda1a8d492848b642a285</gtr:id><gtr:otherNames>Duley L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1361-6137</gtr:issn><gtr:outcomeId>ZV5PYHepDdr</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B2A94614-A652-405D-827F-7566636C6CD1</gtr:id><gtr:title>Exercise or other physical activity for preventing pre-eclampsia and its complications.</gtr:title><gtr:parentPublicationTitle>The Cochrane database of systematic reviews</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ddd7f361ee04efc2d603dd0d819b5059"><gtr:id>ddd7f361ee04efc2d603dd0d819b5059</gtr:id><gtr:otherNames>Meher S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>1361-6137</gtr:issn><gtr:outcomeId>2F8508DF5CD</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D831CDE2-7EAC-40F1-AA45-F499370A47E6</gtr:id><gtr:title>Calcium supplementation during pregnancy for preventing hypertensive disorders and related problems.</gtr:title><gtr:parentPublicationTitle>The Cochrane database of systematic reviews</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c3ae3077040f28290a35def12b185859"><gtr:id>c3ae3077040f28290a35def12b185859</gtr:id><gtr:otherNames>Hofmeyr GJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>1361-6137</gtr:issn><gtr:outcomeId>B26FFF215A3</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D7F8BDB0-229D-4F2E-BBF1-E359E3C59632</gtr:id><gtr:title>Antiplatelet therapy before or after 16 weeks' gestation for preventing preeclampsia: an individual participant data meta-analysis.</gtr:title><gtr:parentPublicationTitle>American journal of obstetrics and gynecology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ddd7f361ee04efc2d603dd0d819b5059"><gtr:id>ddd7f361ee04efc2d603dd0d819b5059</gtr:id><gtr:otherNames>Meher S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0002-9378</gtr:issn><gtr:outcomeId>5a70721714d953.20198125</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>85877A7A-A3F4-4102-98B2-B932024E2B0C</gtr:id><gtr:title>Dietary calcium supplementation for prevention of pre-eclampsia and related problems: a systematic review and commentary.</gtr:title><gtr:parentPublicationTitle>BJOG : an international journal of obstetrics and gynaecology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c3ae3077040f28290a35def12b185859"><gtr:id>c3ae3077040f28290a35def12b185859</gtr:id><gtr:otherNames>Hofmeyr GJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>1470-0328</gtr:issn><gtr:outcomeId>0E8F4823E14</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D934CDD0-2DFC-43DD-B2C0-25CC36A9BF82</gtr:id><gtr:title>Antenatal magnesium individual participant data international collaboration: assessing the benefits for babies using the best level of evidence (AMICABLE).</gtr:title><gtr:parentPublicationTitle>Systematic reviews</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/7b75533f949b393c50a49912e44754ac"><gtr:id>7b75533f949b393c50a49912e44754ac</gtr:id><gtr:otherNames>AMICABLE Group</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>2046-4053</gtr:issn><gtr:outcomeId>m7FSwQX2qcK</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D49A50FE-E852-4468-9F49-ADE9EF22ACC6</gtr:id><gtr:title>Antihypertensive drug therapy for mild to moderate hypertension during pregnancy.</gtr:title><gtr:parentPublicationTitle>The Cochrane database of systematic reviews</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/17621ab07fee5f306b900b6e1e4822c2"><gtr:id>17621ab07fee5f306b900b6e1e4822c2</gtr:id><gtr:otherNames>Abalos E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>1361-6137</gtr:issn><gtr:outcomeId>A6EA3B139D9</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>438BDD64-9D15-4200-BF38-4F8AD7EBFF0F</gtr:id><gtr:title>Garlic for preventing pre-eclampsia and its complications.</gtr:title><gtr:parentPublicationTitle>The Cochrane database of systematic reviews</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ddd7f361ee04efc2d603dd0d819b5059"><gtr:id>ddd7f361ee04efc2d603dd0d819b5059</gtr:id><gtr:otherNames>Meher S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>1361-6137</gtr:issn><gtr:outcomeId>FD68C49DA6F</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>102B579D-6C24-4C0B-9112-B7EC80D722A9</gtr:id><gtr:title>Gestational hypertension before term: observe or deliver?</gtr:title><gtr:parentPublicationTitle>Lancet (London, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/43fa32ea768dcee22b194ce6ff76771d"><gtr:id>43fa32ea768dcee22b194ce6ff76771d</gtr:id><gtr:otherNames>Thornton J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0140-6736</gtr:issn><gtr:outcomeId>5a7081339737e5.31038034</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0E46E90B-5A02-4799-833F-871D2924746E</gtr:id><gtr:title>Magnesium sulphate versus lytic cocktail for eclampsia.</gtr:title><gtr:parentPublicationTitle>The Cochrane database of systematic reviews</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/eb3d1e6636ccda1a8d492848b642a285"><gtr:id>eb3d1e6636ccda1a8d492848b642a285</gtr:id><gtr:otherNames>Duley L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1361-6137</gtr:issn><gtr:outcomeId>VJ7sUz4XUeP</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">G116/98</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>FA7AA693-7EDD-4A7E-8CA3-6B5658FBF717</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Reproductive Health and Childbirth</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>1BF330A9-C7B5-49C5-B54B-CF4FAE6DF1D8</gtr:id><gtr:percentage>75</gtr:percentage><gtr:text>2.1  Biological and endogenous factors</gtr:text></gtr:researchActivity><gtr:researchActivity><gtr:id>7135039D-2DB0-4D41-87B3-FA1C8D38E133</gtr:id><gtr:percentage>25</gtr:percentage><gtr:text>6.1  Pharmaceuticals</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>